Buying Time

In a desperate attempt to save his ailing mother, a young man named Charles finds himself entangled in a dangerous world of illegal organ harvesting. He makes a pact with a shadowy broker, agreeing to sell his own kidney to fund her life-saving treatment. However, as the operation draws nearer, Charles uncovers the horrific extent of the broker's operations and realizes he may become another victim.

Buying Time received mixed to negative reviews from critics and audiences alike. While some praised its ambition and a few performances, many found the plot underdeveloped and predictable, with a lack of emotional depth. The film struggled to resonate with viewers, leading to a lukewarm reception.

• The film attempts a thriller premise but falters in execution.

• Performances are earnest but unable to elevate the weak script.

• Lacks the tension and emotional impact to be truly engaging.

Google audience: Audience reviews indicate a general disappointment with the film's predictable storyline and unconvincing plot points. Many viewers found it to be a low-budget production that failed to deliver on its thriller elements, with some expressing that it felt like a 'made-for-TV' movie.

The film's director, Charles H. Joslin, also stars in the lead role and co-wrote the screenplay, making it a highly personal project for him.